Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2023-12-07

Clinical Trial Update: Efficacy and Safety of BIIB111 for the Treatment of Choroideremia [Phase 3]

View source ↗

Summary

Phase 3 trial updates the efficacy and safety of BIIB111 for treating choroideremia; results have been posted after completion.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • BIIB111

Snippet

Sponsor: Biogen | Conditions: Choroideremia | Phase 3 | Status: COMPLETED | Results posted: 2023-12-07